Disease characterization using LQTS-specific induced pluripotent stem cells
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
AIMS: Long QT syndrome (LQTS) is an inheritable and life-threatening disease; however, it is often difficult to determine disease characteristics in sporadic cases with novel mutations, and more precise analysis is necessary for the successful development of evidence-based clinical therapies. This study thus sought to better characterize ion channel cardiac disorders using induced pluripotent stem cells (iPSCs). METHODS AND RESULTS: We reprogrammed somatic cells from a patient with sporadic LQTS and from controls, and differentiated them into cardiomyocytes through embryoid body (EB) formation. Electrophysiological analysis of the LQTS-iPSC-derived EBs using a multi-electrode array (MEA) system revealed a markedly prolonged field potential duration (FPD). The IKr blocker E4031 significantly prolonged FPD in control- and LQTS-iPSC-derived EBs and induced frequent severe arrhythmia only in LQTS-iPSC-derived EBs. The IKs blocker chromanol 293B did not prolong FPD in the LQTS-iPSC-derived EBs, but significantly prolonged FPD in the control EBs, suggesting the involvement of IKs disturbance in the patient. Patch-clamp analysis and immunostaining confirmed a dominant-negative role for 1893delC in IKs channels due to a trafficking deficiency in iPSC-derived cardiomyocytes and human embryonic kidney (HEK) cells. CONCLUSIONS: This study demonstrated that iPSCs could be useful to characterize LQTS disease as well as drug responses in the LQTS patient with a novel mutation. Such analyses may in turn lead to future progress in personalized medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [6]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [6]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [6]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Human-induced pluripotent stem cells (hiPSCs) have become a promising tool for analysing human genetic diseases.(8,9) Many studies have already shown that apparent cellular phenotypes of familial genetic disorders are recapitulated by disease-specific iPSC-derived cells in vitro.”
BackgroundZipes, D. P., & Wellens, H. J. J. (1998) · Circulation · doi:10.1161/01.cir.98.21.2334 · Cited by 2,744
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Sudden Death Due to Cardiac Arrhythmias
Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000650 · Cited by 1,466
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251 · cited 1×
“However, most patients for generating iPSCs in previous reports were already diagnosed with responsible genes and/or had familial history.(10) –13,31,32 We showed here that iPSCs can recapitulate the phenotype of a sporadic patient with LQTS type1.”
BackgroundZipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Low Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728
Cited by
Karakikes, I., Ameen, M., Termglinchan, V., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.117.305365 · Cited by 478
Induced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Denning, C., Borgdorff, V., Crutchley, J., Firth, K. S. A., George, V., Kalra, S., Kondrashov, A., Hoang, M. D., Mosqueira, D., Patel, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.014 · Cited by 293
“For the heart, side effects can damage the structural integrity and survival of cardiomyocytes (CMs), as is the case with the anti-inflammatory drug, Vioxx [8], and many anti-cancer drugs, such as doxorubicin [9].”
BackgroundTranslation of Human-Induced Pluripotent Stem Cells
Sayed, N., Liu, C., & Wu, J. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.083 · Cited by 279
Metadata
- Authors
- Egashira, T., Yuasa, S., Suzuki, T., Aizawa, Y., Yamakawa, H., Matsuhashi, T., Ohno, Y., Tohyama, S., Okata, S., Seki, T., Kuroda, Y., Yae, K., Hashimoto, H., Tanaka, T., Hattori, F., Sato, T., Miyoshi, S., Takatsuki, S., Murata, M., Kurokawa, J., Furukawa, T., Makita, N., Aiba, T., Shimizu, W., Horie, M., Kamiya, K., Kodama, I., Ogawa, S., & Fukuda, K.
- Affiliations
- Keio University (JP)
- Tokyo Medical and Dental University (JP)
- Nagasaki University (JP)
- National Cerebral and Cardiovascular Center (JP)
- Shiga University of Medical Science (JP)
- Research Institute of Environmental Medicine, Nagoya University (JP)
- Corresponding author
- Yuasa, Shinsuke
- Fukuda, Keiichi
- ORCID
- Yuasa, Shinsuke
- Suzuki, Tomoyuki
- Aizawa, Yoshiyasu
- Yamakawa, Hiroyuki
- Matsuhashi, Tomohiro
- Ohno, Yohei
- Tohyama, Shugo
- Seki, Tomohisa
- Kuroda, Yusuke
- Yae, Kojiro
- Hashimoto, Hisayuki
- Tanaka, Tomofumi
- Hattori, Fumiyuki
- Sato, Toshiaki
- Takatsuki, Seiji
- Murata, Mitsushige
- Kurokawa, Junko
- Furukawa, Tetsushi
- Makita, Naomasa
- Aiba, Takeshi
- Shimizu, Wataru
- Horie, Minoru
- Ogawa, Satoshi
- Fukuda, Keiichi
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-27
- Volume
- 95
- Issue
- 4
- Pages
- 419-429
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2133808555
- Cited by
- 178
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 16 · 2020: 11 · 2019: 5 · 2018: 12 · 2017: 19 · 2016: 23 · 2015: 29 · 2014: 16 · 2013: 17 · 2012: 5
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22590779, 22590813, 23590297, 22689027, 24591086, 23790873, 24390199)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome, induced pluripotent stem cells, iPSC-derived cardiomyocytes, embryoid body differentiation, field potential duration, IKs channel, dominant negative effect, ion channel trafficking, E-4031, chromanol 293B, cardiac arrhythmias, personalized medicine, novel mutations
- MeSH terms
- Action Potentials, Adolescent, Animals, Cell Differentiation, Fluorescent Antibody Technique, Humans, Male, Phenotype, Teratoma, Time Factors, Transfection, Patch-Clamp Techniques, Gene Expression Regulation, Developmental, Coculture Techniques, Genetic Predisposition to Disease, Potassium Channels, Voltage-Gated, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, Mice, KCNQ1 Potassium Channel, Intermediate-Conductance Calcium-Activated Potassium Channels, Induced Pluripotent Stem Cells, HEK293 Cells, Embryoid Bodies, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disease characterization using LQTS-specific induced pluripotent stem cells. https://app.cochat.ai/papers/10.1093/cvr/cvs206
- The paper
- Egashira, T., Yuasa, S., Suzuki, T., Aizawa, Y., Yamakawa, H., Matsuhashi, T., Ohno, Y., Tohyama, S., Okata, S., Seki, T., Kuroda, Y., Yae, K., Hashimoto, H., Tanaka, T., Hattori, F., Sato, T., Miyoshi, S., Takatsuki, S., Murata, M., . . . Fukuda, K. (2012). Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovascular Research. https://doi.org/10.1093/cvr/cvs206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.